Meena Shatby, MD
Foot and Ankle Surgery · The Woodlands, TXNPI 1922166040
Payments from drug & device makers
Across 38 payments — averaging $114.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Medical Device Business Services, Inc.$1K
- Medinc Of Texas$505
- Johnson & Johnson$410
- Smith+Nephew$402
- Bone Support Inc.$148
- plus $272 from 8 others
What the payments were for
- Travel & lodging$2,00946%
- Food & beverage$1,13826%
- Education$1,20028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,395 |
| Medical Device Business Services, Inc. | 6 | $1,214 |
| Medinc Of Texas | 2 | $505 |
| Johnson & Johnson | 7 | $410 |
| Smith+Nephew | 4 | $402 |
| Bone Support Inc. | 1 | $148 |
| Pacira Therapeutics, Inc. | 5 | $102 |
| Encore Medical, LP | 2 | $49 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| Bioventus LLC | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Zimmer Biomet | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$1,100
- REAL INTELLIGENCE$291
- CERAMENTBONE VOID FILLER$148
- CERAMENT G$148
- VA-LCP$115
How this compares
$4,346 in reported general payments places this provider in the 50th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 93 | $2,158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 146 | $1,214 |
| Hydroxyzine Pamoate | 74 | $463 |
| Methylprednisolone | 56 | $331 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $128 |
| Gabapentin | 16 | $96 |
| Meloxicam | 11 | $72 |
| Cyclobenzaprine Hcl | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in The Woodlands
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
- Mark RobsonAustin$957K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.